Pharma Research Services (CROs/SMOs)
Contract research organisations and site management organisations deliver outsourced trial execution and patient recruitment.
Capturing Value in Clinical Research and Site Management
Clinical research organisations (CROs) and site management organisations (SMOs) are central to the delivery of modern drug development. Demand for outsourced services continues to grow as sponsors seek efficiency, access to specialist expertise, and global reach.
President Donald Trump’s threats to tariff pharmaceutical companies have had a marked impact, with pharmaceutical companies being told to conduct more of their clinical research on US patients.
We support investors and management teams in evaluating opportunities across the clinical services landscape. Our work includes commercial due diligence, transaction support, and growth strategy development. We assess market dynamics by geography and therapeutic area, benchmark financial performance, and analyse contract pipelines to provide a realistic view of growth prospects.
Our pharma services (CROs/SMOs) leads
Our teams combine scientific and operational knowledge with transaction experience. We review competitive positioning, pricing structures, regulatory expectations, and digital adoption to understand where genuine differentiation exists. This ensures investment cases are built on credible assumptions and highlight where risks may outweigh opportunities.
Beyond transaction assessments, we advise on strategic growth levers such as service line expansion, geographic scaling, and partnership strategies with pharma and biotech sponsors. By combining rigorous analysis with practical insight, we help CROs and SMOs position for sustainable growth in an increasingly sophisticated and global market.
News & Insights
